|
|
|

|
|
Walder Wyss Ltd. Seefeldstrasse 123 P.O. Box 8034 Zurich Switzerland Telephone +41 58 658 58 58 Fax +41 58 658 59 59 www.walderwyss.com |
To:
CRISPR Therapeutics AG
Baarerstrasse 14
6300 Zug
Switzerland
Zurich, as of October 15, 2025
CRISPR Therapeutics AG – Swiss Legal Opinion (Securities Registered under Registration Statement on Form S-3)
Dear Madam, Dear Sir,
We have acted as Swiss counsel to CRISPR Therapeutics AG, Zug, Switzerland (the Company) on matters of Swiss law in connection with the Company’s filing of a registration statement on Form S-3 automatic shelf registration (as amended or supplemented, the Registration Statement) filed on 5 August 2024 with the U.S. Securities and Exchange Commission (the SEC) pursuant to the Securities Act of 1933, as amended (the Securities Act), relating to the registration of the offering by the Company of certain securities, including common shares, par value of CHF 0.03 each, of the Company (such common shares, the Common Shares). Reference is made to our opinion letter dated 5 August 2024 and included as Exhibit 5.1 to the Registration Statement. We are delivering this supplemental opinion letter in connection with the sale agreement prospectus supplement (the Prospectus) contained in the Registration Statement. The Prospectus relates to the offering by the Company of Common Shares, having an aggregate offering price of up to $600,000,000 (the Offered Shares) covered by the Registration Statement. The Offered Shares are being offered and sold in accordance with a certain Open Market Sale AgreementSM dated 30 August 2019 (the Sale Agreement), entered into between the Company and Jefferies LLC.
As such counsel, we have been requested to render an opinion as to certain matters of Swiss law.
1.Scope and Limitation of Opinion
Our opinion is strictly confined to matters of Swiss law as in force at the date hereof and as it is presently applied by the Swiss courts. Such law and its interpretation are subject to change. In the absence of explicit statutory law or established case law, we base our opinion solely on our independent professional judgment. Our opinion is strictly limited to the Documents (as defined below) and the matters stated herein and is not to be read as extending, by implication or otherwise, to any agreement or document referred to in any of the Documents or any other matter. For purposes of this opinion, we have not conducted any due diligence or similar investigation or verification as to any matters stated herein. In this opinion, Swiss legal concepts are expressed in English terms and not in their original language. These concepts may not be identical to the concepts described by the same English language terms as they exist under the laws of other jurisdictions.
For purposes of rendering the opinion expressed herein, we have received the following documents (the Documents):
(a)a .pdf copy of the Registration Statement, including the Prospectus contained therein;
(b)a .pdf copy of the Sale Agreement;
(c)a .pdf copy of the public deed on the resolutions of the Company’s ordinary shareholders’ meeting dated 30 May 2024, approving, inter alia, certain changes to the Company’s articles of association (the AGM Resolution);
(d)a certified copy of the articles of association of the Company in their version of 14 October 2025 (the Articles);
(e)a .pdf copy of the organizational regulations of the Company dated 11 February 2025 (the Organizational Regulations);
(f)a .pdf copy of a certified excerpt from the registry of the Commercial Register of the Canton of Zug, dated 17 September 2025 relating to the Company (the Excerpt) as confirmed by an online excerpt on the date hereof;
(g)a .pdf copy of the base prospectus dated 5 August 2024, included in the Registration Statement (the Base Prospectus);
relating thereto (the Board Resolution 8, together with the Board Resolution 1, the Board Resolution 2, the Board Resolution 3, the Board Resolution 4, the Board Resolution 5, the Board Resolution 6, and the Board Resolution 7, the Board Resolutions).
No documents have been reviewed by us in connection with this opinion other than the Documents listed in this Section 2 (Documents).
All terms used in this opinion in uppercase form shall have the meaning ascribed to them in the Registration Statement, unless otherwise defined herein.
In rendering the opinion below, we have assumed:
(a)the conformity to the Documents of all documents produced to us as copies, fax copies or via e-mail, and that the original was executed in the manner appearing on the copy of the draft;
(b)the genuineness and authenticity of the signatures on all copies of the original Documents thereof which we have examined, and the accuracy of all factual information contained in, or statements given in connection with, the Documents;
(c)the AGM Resolution has been duly resolved in meetings duly convened and has not been rescinded or amended and is in full force and effect;
(d)the Board Resolutions have been duly resolved in meetings duly convened or, as applicable, in duly executed circular resolutions, and have not been rescinded or amended and are in full force and effect;
(e)that the information provided in the Documents (in particular in the Excerpt, the Articles and the Organizational Regulations) are true, correct, complete and up to date as of the date hereof and that there are no facts outstanding or matters resolved that are not reflected in the Documents;
(f)the Registration Statement has been, or will be, duly filed by the Company;
(g)the legal capacity, power and authority of each of the parties (other than the Company) to enter into and perform its obligations under the Sale Agreement and the relevant transaction provided
(k)prior to the issuance and delivery of any Offered Shares, the Board shall have duly authorized the issuance of such Offered Shares in accordance with the Articles, and such authorization shall not have been amended or rescinded, and all necessary corporate actions of the Company to approve the issuance and sale of the Offered Shares shall have been performed in accordance with the Board Resolutions and the Articles;
(l)that the issuance, transfers, offering and sale of the Offered Shares will be conducted in the manner as described in the Articles, the Registration Statement, the Prospectus, the Sale Agreement and the Board Resolutions;
(m)that the Offered Shares have not been and will not be (i) publicly offered, directly or indirectly, in Switzerland within the meaning of article 3 lit. h of the Swiss Financial Services Act of 15 June 2018 and/or (ii) admitted to any trading venue in Switzerland; and
(n) all parties to the Sale Agreement will perform all obligations by which they are bound in accordance with the respective terms.
Based upon the foregoing and subject to the qualifications referred to below, we are of the following opinion:
The Offered Shares, if and when issued, will be validly issued, fully paid in (up to their nominal value) and non-assessable.
The opinion set-forth above is subject to the following qualifications:
(a)The lawyers of our firm are members of the Swiss bar and do not hold themselves to be experts in any laws other than the laws of Switzerland. Accordingly, we are opining herein as to Swiss law only and we express no opinion with respect to the applicability thereto, or the effect thereon, of the laws of any other jurisdiction.